tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Stoke Therapeutics: Promising Outlook with Strong Financial Position and Advancing Clinical Trials Justifies Buy Rating
PremiumRatingsStoke Therapeutics: Promising Outlook with Strong Financial Position and Advancing Clinical Trials Justifies Buy Rating
24d ago
Promising Developments in Stoke Therapeutics’ Clinical Trials Support Buy Rating
Premium
Ratings
Promising Developments in Stoke Therapeutics’ Clinical Trials Support Buy Rating
24d ago
Positive Outlook for Stoke Therapeutics: Promising Clinical Data and Strong Financial Position
Premium
Ratings
Positive Outlook for Stoke Therapeutics: Promising Clinical Data and Strong Financial Position
25d ago
STOK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsSTOK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
28d ago
Stoke Therapeutics initiated with a Buy at Jefferies
Premium
The Fly
Stoke Therapeutics initiated with a Buy at Jefferies
2M ago
Stoke Therapeutics’ EMPEROR Study: A New Hope for Dravet Syndrome
Premium
Company Announcements
Stoke Therapeutics’ EMPEROR Study: A New Hope for Dravet Syndrome
2M ago
Positive Outlook on Stoke Therapeutics: Buy Rating Affirmed Amid Promising Phase 3 Trial for Dravet Syndrome Treatment
PremiumRatingsPositive Outlook on Stoke Therapeutics: Buy Rating Affirmed Amid Promising Phase 3 Trial for Dravet Syndrome Treatment
2M ago
Stoke Therapeutics Advances Phase 3 Study for Dravet Syndrome Treatment
Premium
Company Announcements
Stoke Therapeutics Advances Phase 3 Study for Dravet Syndrome Treatment
2M ago
Stoke Therapeutics Adopts Key Proposals at Annual Meeting
Premium
Company Announcements
Stoke Therapeutics Adopts Key Proposals at Annual Meeting
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100